![](/img/cover-not-exists.png)
Safety and efficacy at 1 year after switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in chronic HBV patients with risk factors for TDF use
Gane, E., Seto, W.-K., Janssen, H., Caruntu, F.A., Kim, H.J., Abdurakhmanov, D., Nishiguchi, S., Andrzej, H., Bae, H., Mo, S., Suri, V., Gaggar, A., Flaherty, J.F., Kao, J.-H., Brunetto, M., Ferret, MVolume:
68
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/s0168-8278(18)30392-1
Date:
April, 2018
File:
PDF, 52 KB
english, 2018